12 March 2021 News release Geneva The World Health Organization (WHO) listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The …
Category:
Global Health News
- Global Health NewsPublic Health NewsVector-Borne Diseases(VBDs)
El Salvador certified as malaria-free by WHO
El Salvador is first Central American country to achieve this status, third in all of the Americas in recent years GENEVA and WASHINGTON, D.C. (WHO/PAHO) – El Salvador today became El …
- Outbreak NewsGlobal Health NewsPublic Health News
No-fault compensation programme for COVID-19 vaccines is a world first
The World Health Organization (WHO) and Chubb Limited (NYSE: CB), through ESIS Inc., a Chubb company, signed an agreement on behalf of the COVAX Facility on 17 February 2021 for …
- Research & PublicationCommunicable DiseasesGlobal Health NewsInternational Plan, Policy & GuidelinesPublic Health Update
WHO Guidelines for Malaria (Consolidated Guidelines for Malaria)
WHO launches a consolidated guidelines for malaria. The consolidated WHO Guidelines for malaria present all of the current WHO recommendations for malaria. This guideline bring together the Organization’s most up-to-date recommendations for malaria …
Declaration We must accelerate vaccine equity for all health workers – now Health and care workers have been at the forefront of the pandemic response: often under protected and over …
- Outbreak NewsGlobal Health NewsPublic Health News
WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out
AstraZeneca/Oxford-developed vaccines to reach countries in the coming weeks 15 February 2021 The World Health Organization (WHO) listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the …
- Global Health NewsEnvironmental Health & Climate ChangePublic Health EventsSymposium
The CIH-LMU Symposium on Global Health Perspectives: Climate Change and Migration
The CIHLMU Symposium on Global Health Perspectives: Climate Change and Migration will be held on Friday, March 12, 2021. The effects of climate change cannot be emphasized enough. Climate change is …
- Public Health UpdateCommunicable DiseasesGlobal Health NewsInternational Plan, Policy & Guidelines
WHO announces updated critical concentrations for susceptibility testing for rifampicin
5 February 2021 | GENEVA – The critical concentrations for culture-based phenotypic drug susceptibility testing (DST) to first-line anti-TB drugs have been revised by the the World Health Organization (WHO). Critical concentrations …
- ActivitiesCommunicable DiseasesGlobal Health NewsPublic Health NewsPublic Health Update
WHO announces updated definitions of extensively drug-resistant tuberculosis
27 January 2021 | GENEVA – The definition of extensively drug-resistant tuberculosis (XDR-TB) has been revised by the World Health Organization (WHO)’s Global TB Programme, who have also defined pre-XDR-TB for the …
- National Health NewsGlobal Health NewsOutbreak NewsPublic Health News
DDA approves ‘COVISHIELD’ vaccine for emergency use in Nepal
The Department of Drug Administration (DDA) has decided to approve ‘COVISHIELD’ COVID-19 vaccine for emergency use in Nepal. DDA provided the conditional permission for emergency authorisation of COVISHEILD vaccine against …
